H6PD and Facioscapulohumeral dystrophy: In the pentose phosphate pathway (PPP), mild FSHD patients exhibited increased levels of hexose-6-phosphate dehydrogenase (H6PD), a significant source of reducing power and metabolic intermediates that can be used as an alternative to glycolysis.